2-Benzyl-2-methyl-3-butenitrile
Common Name: |
2-Benzyl-2-methyl-3-butenitrile |
IUPAC Name: |
2-benzyl-2-methylbut-3-enenitrile |
Molecular Formula: |
C12H13N |
SMILES: |
CC(CC1=CC=CC=C1)(C=C)C#N |
Inchi: |
1S/C12H13N/c1-3-12(2,10-13)9-11-7-5-4-6-8-11/h3-8H,1,9H2,2H3 |
Inchi Key: |
UKLOORXNVRHFRM-UHFFFAOYSA-N |
Cas No: |
97384-48-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
171.24 |
Mass (g/mol) |
171.105 |
Molar Refractivity |
54.46 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
23.79 |
Hetero Atoms |
1 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
285.00 to 286.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.003 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.25 |
LogP |
2.945 |
iLOGP |
2.26 |
XLOGP3 |
3.08 |
WLOGP |
2.94 |
MLOGP |
2.89 |
ESOL Log S |
-2.99 |
ESOL Solubility (mg/ml) |
0.177 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.25 |
Ali Solubility (mg/ml) |
0.1 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.76 |
Silicos-IT Solubility (mg/ml) |
0.03 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.16 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.053 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.597 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |